Trump administration signals international pricing index, importation rules are advancing

The Trump administration Wednesday published clues about pending proposed rules that would create a foreign reference pricing benchmark for Medicare Part B drug prices and allow importation of prescription drugs.

The White House Office of

Read the full 354 word article

User Sign In